Pharmacists in Wichita Falls, Texas


93 Pharmacists found in Wichita Falls
female pharmacist

Shari Zaloski, RPH


Pharmacist
4516 Jacksboro Hwy, Wichita Falls, TX 76302
940-767-3368    

female pharmacist

Ms. Sheryll Lanette Elliott


Pharmacist
2700 Central Fwy, Wichita Falls, TX 76306
940-855-2374     940-851-8782

female pharmacist

Sierra Nicole Jones


Pharmacist
4600 Southwest Pkwy, Wichita Falls, TX 76310
940-696-0141     940-696-8154



female pharmacist

Mrs. Susan Gail Gillis


Pharmacist
1701 9th St, Wichita Falls, TX 76301
940-723-7979    

female pharmacist

Tammy Elliott Kowing, PHARMD


Pharmacist
4600 Kell Blvd, Wichita Falls, TX 76310
940-692-4610    

female pharmacist

Dr. Tandy M Martin, PHARM D.


Pharmacist
4590 Kell Blvd, Wichita Falls, TX 76309
940-447-5544    

male pharmacist

Taylor Anthony Tomasino, PHARMD


Pharmacist
4426 Kell Blvd, Wichita Falls, TX 76309
800-460-5282    

female pharmacist

Dr. Terri Paulson


Pharmacist
3130 Lawrence Rd, Wichita Falls, TX 76308
940-689-9762    

male pharmacist

Timothy Andrew Guitard, RXM


Pharmacist
1701 9th St, Wichita Falls, TX 76301
940-723-7979    

female pharmacist

Trudie Lenhardt, PHARM D


Pharmacist
3801 Kell Blvd, Wichita Falls, TX 76308
940-691-7296     940-691-2872

male pharmacist

Tyle Cash Rushing, PHARMACIST


Pharmacist
4590 Kell Blvd, Wichita Falls, TX 76309
940-716-2515    

male pharmacist

Vineet Gupta, R.PH, PH.D


Pharmacist
4600 Kell Blvd, Wichita Falls, TX 76310
940-692-4610    

male pharmacist

William W. Chiang, PHARM.D.


Pharmacist
4600 Kell Blvd, Wichita Falls, TX 76310
940-692-4610    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.